Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00351559 · ClinicalTrials.gov registry record · NA
IMAGE: A Comparison of AlloMap Molecular Testing and Traditional Biopsy-based Surveillance for Heart Transplant Rejection
A NA study, sponsored by XDx.
- Completed
- Registry status
- NA
- Development phase
- 629
- Enrollment target
NCT00351559 is a NA study that has completed, run by XDx. The registered enrollment target is 629 participants.
The verdict
NCT00351559, a NA study, has completed, sponsored by XDx.
- COMPLETED
- Registry status
- NA
- Development phase
- 629 participants
- Enrollment target
Study Summary
This study is designed to evaluate the safety and efficacy of a leukocyte gene expression profiling method in the monitoring of asymptomatic heart transplant patients for acute rejection.
Interventions
- DEVICE AlloMap molecular expression testing
- PROCEDURE Right ventricular endomyocardial biopsy
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 629 participants |
| Start Date | 2005-01 |
| Est. Completion | 2009-10 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00351559
The ClinicalTrials.gov registry entry for NCT00351559 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 629 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is XDx, which has 3 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which AlloMap molecular expression testing is the first listed.
NCT00351559 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00351559 about?
NCT00351559 is a clinical study titled "IMAGE: A Comparison of AlloMap Molecular Testing and Traditional Biopsy-based Surveillance for Heart Transplant Rejection". This study is designed to evaluate the safety and efficacy of a leukocyte gene expression profiling method in the monitoring of asymptomatic heart transplant patients for acute rejection.
What is the current status of trial NCT00351559?
This trial is currently completed. It is a NA study. The enrollment target is 629 participants. The study started on 2005-01. Estimated completion is 2009-10.
What interventions are being tested in trial NCT00351559?
The interventions under investigation include: AlloMap molecular expression testing (DEVICE), Right ventricular endomyocardial biopsy (PROCEDURE).
Who is sponsoring clinical trial NCT00351559?
This trial is sponsored by XDx, which has 3 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.